Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa Waberer
Observed names:
L. Waberer,
Waberer, Lisa
Institution:
Krankenhaus Nordwest
Observed institutions:
Goethe University Frankfurt,
Institute of Clinical Cancer Research,
Krankenhaus Nordwest
OpenAlex ID:
A5061372008
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial
2022
·
Georg Martin Haag
, Christoph Springfeld
, et al.
·
European Journal of Cancer
·
117
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
2021
·
Alexander Stein
, Donjete Simnica
, et al.
·
Journal for ImmunoTherapy of Cancer
·
68
PDF
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).
2020
·
Alexander Stein
, Mascha Binder
, et al.
·
Journal of Clinical Oncology
·
55
1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
2021
·
S-E. Al-Batran
, S. Lorenzen
, et al.
·
Annals of Oncology
·
35
Combined PD-1 inhibition (Pembrolizumab) and CCR5 inhibition (Maraviroc) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): First results of the PICCASSO phase I trial.
2020
·
Georg Martin Haag
, Niels Halama
, et al.
·
Journal of Clinical Oncology
·
28
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Results of the safety run-in phase of the phase II AVETUX trial (AIO-KRK-0216).
2018
·
Alexander Stein
, Mascha Binder
, et al.
·
Journal of Clinical Oncology
·
25
Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK.
2019
·
Salah-Eddin Al-Batran
, Claudia Pauligk
, et al.
·
Journal of Clinical Oncology
·
23
The synaptic vesicle protein SV 31 assembles into a dimer and transports Zn2+
2016
·
Lisa Waberer
, Erik Henrich
, et al.
·
Journal of Neurochemistry
·
22
PDF
Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma—A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK.
2020
·
Nils Homann
, Sylvie Lorenzen
, et al.
·
Journal of Clinical Oncology
·
14
Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK
2019
·
S.-E. Al-Batran
, C. Pauligk
, et al.
·
Annals of Oncology
·
9
PDF
1494P Updated safety data of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma - A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK
2020
·
S-E. Al-Batran
, S. Lorenzen
, et al.
·
Annals of Oncology
·
7
PDF
Safety of perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: An interim safety analysis of the DANTE, a randomized, open-label phase II trial of the German Gastric Group at the AIO and the SAKK.
2020
·
Salah-Eddin Al-Batran
, Sylvie Lorenzen
, et al.
·
Journal of Clinical Oncology
·
7
1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
2021
·
C. Kopp
, S. Lorenzen
, et al.
·
Annals of Oncology
·
3
PDF
PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy: Results from the FLOT4 phase III trial of the AIO.
2018
·
Lisa Waberer
, Nils Homann
, et al.
·
Journal of Clinical Oncology
·
1
IRITACE: Transarterielle Chemoembolisation (TACE) mit Irinotecan und Mitomycin C im Vergleich zu TACE mit Doxorubicin bei Patienten mit nicht kurativ behandelbarem hepatozellulärem Karzinom (AIO-HEP-0220/ass)
2020
·
L. Waberer
, J. Riedel
, et al.
·
Forum
Show more works
View as search
Works count:
16
Citation count:
414
H-index:
9
I10-index:
9
Year
Topic
Type